ClinicalTrials.Veeva

Menu

Measuring Aided Language Development (MALD)

University of Central Florida logo

University of Central Florida

Status

Enrolling

Conditions

Speech Sound Disorder
Apraxia of Speech
Down Syndrome
Cerebral Palsy
Speech and Language Disorder
Speech Disorders in Children

Treatments

Behavioral: AAC Generative Language Intervention

Study type

Interventional

Funder types

Other
NIH

Identifiers

NCT06512168
AWD00006137
1R01DC021160-01A1 (U.S. NIH Grant/Contract)

Details and patient eligibility

About

The focus of the current study is to systematically investigate the psychometric properties of a range of aided language measures, which are based on the Graphic Symbol Utterance and Sentence Development Framework (Binger & Kent-Walsh).

Full description

Our central hypotheses are: (1) psychometrically sound measures can be established to capture growth within and across different dimensions of language acquisition, and (2) some elicitation contexts will be better than others at capturing aided language growth. Specific Aim 1 identifies valid measures to characterize aided language progress. Aim 1A uses existing data to document the psychometric properties of a range of aided language measures for preschoolers at the early stages of aided communication acquisition who have received 4 months of aided language intervention. Aim 1B analyzes language progression for high-performing aided communicators who will receive 24 months of intervention; this allows for investigation across all phases of early aided language acquisition. Specific Aim 2 identifies elicitation contexts that demonstrate the most productive aided language use. Achievement of the aims will result in measures that demonstrate strong reliability, differentiate growth for different populations, describe different dimensions of language growth, and are clinically feasible.

Enrollment

60 estimated patients

Sex

All

Ages

42 to 60 months old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Clinical Identification of Down Syndrome or Cerebral Palsy + Significant Speech Impairment
  • Must Speak English as a Primary Language
  • Must Be Able to Express At Least 25 Words (using any communication mode)
  • Must Be Able to Accurately Select Picture Symbols on iPad Communication App with at Least 50% Accuracy
  • Vision and Hearing within Functional Limits or Corrected to be within Functional Limits for Study Activities

Exclusion criteria

  • Clinical Diagnosis of Autism or Social Communication Disorder
  • Primary Language Spoken is A Language Other than English

Trial design

Primary purpose

Diagnostic

Allocation

N/A

Interventional model

Single Group Assignment

Masking

None (Open label)

60 participants in 1 patient group

Treatment Group
Experimental group
Description:
AAC Generative Language Intervention
Treatment:
Behavioral: AAC Generative Language Intervention

Trial contacts and locations

1

Loading...

Central trial contact

Cathy Binger, PhD; Jennifer Kent-Walsh, PhD

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems